Cardiovascular risk markers in pregnancies complicated by diabetes mellitus or preeclampsia
M Sugulle, F Herse, M Seiler, R Dechend… - … : An International Journal …, 2012 - Elsevier
Objective To explore biomarkers indicating cardiovascular disease in pregnant women with
diabetes or preeclampsia, since these women are at increased risk for future cardiovascular
disease. Study design EDTA-plasma from 262 women in gestational week 24–42 (healthy
pregnancies n= 71, preeclampsia n= 105, type 2 diabetes n= 17, gestational diabetes n= 61,
diabetes with preeclampsia n= 8) was analyzed by immunoassay for neopterin, midregional
pro-adrenomedullin (MR-proADM) and C-terminal pro-arginine vasopressin (CT-proAVP) …
diabetes or preeclampsia, since these women are at increased risk for future cardiovascular
disease. Study design EDTA-plasma from 262 women in gestational week 24–42 (healthy
pregnancies n= 71, preeclampsia n= 105, type 2 diabetes n= 17, gestational diabetes n= 61,
diabetes with preeclampsia n= 8) was analyzed by immunoassay for neopterin, midregional
pro-adrenomedullin (MR-proADM) and C-terminal pro-arginine vasopressin (CT-proAVP) …